• Features of the hemostasis procoagulation link, pregnancy outcomes and parturition in HIV-infected women

Features of the hemostasis procoagulation link, pregnancy outcomes and parturition in HIV-infected women

HEALTH OF WOMAN. 2018.4(130):43–47; doi 10.15574/HW.2018.130.43

Savchenko S. E. , Kolomiychenko T. V. , Gervazyuk O. I.
Shupyk National Medical Academy of Postgraduate Education, Kiev
Kiev city center of reproductive and perinatal medicine

The objective: to study the changes in the procoagulant link of the hemostasis system, the course of pregnancy and parturition peculiarities in HIV-infected women, depending on the clinical stage and the onset of haart.

Materials and methods. In 150 HIV-infected pregnant women and parturients, a procoagulant link of hemostasis was evaluated by meanings of total fibrinogen, prothrombin, activated fractional thromboplastin time, as well as the status of the mother-placenta-fetus system and periportal blood loss amount.

Results. Study of the procoagulant link in women with II and III clinical stages of HIV-infection in the second trimester showed a tendency to a hypercoagulative conditions, with increased levels of fibrinogen, prothrombin and short activated fractional thromboplastin time. In the third trimester, these patients already had a significant difference in these parameters compared to the control group (p<0.05). Laboratory changes in the 3rd trimester correlate with impairment of the «mother–placenta–fetus» system discovered by ultrasound and doplerometry in the vast majority of pregnant women with II and III clinical stages (p<0.05). A state of hypocoagulation is observed during parturirion in women with the III clinical stage of HIV-infection and in parturients who started taking HAART during this pregnancy (p<0.05).

Conclusions. The pregnancy course in women with II and III clinical stages of HIV-infection is characterized by the presence of gestational and perinatal complications caused by hypercoagulation. During parturirion in HIV-infected patients with the III clinical stage and in parturients who started taking HAART during this pregnancy, there is a tendency to periportal haemorrages, which confirmes by coagulogram changes.

Key words: HIV-infected pregnant women, HIV-infected parturient, procoagulant link of hemostasis system, mother-placenta-fetus system, periportal blood loss.

REFERENCES

1. Aleksandrova EV i dr. 2013. Sistema regulyatsii agregatnogo sostoyaniya krovi: komponentyi, funktsii, diagnostika narusheniy.

2. Makatsariya AD i dr. 2015. Beremennost vyisokogo riska: monografiya. Red. A.D. Makatsariya, F.A. Chervenaka, V.O. Bitsadze. M, MIA:920.

3. Berkovskiy AL i dr. 2016. Skriningovyie testyi plazmennogo gemostaza. Metodyi issledovaniya. M:70.

4. Vartanov VYa i dr. 2011. Profilaktika i lechenie gipokoagulyatsionnyih krovotecheniy u VICh-infitsirovannyih beremennyih. Tolyattinskiy meditsinskiy konsilium 5–6:22–27.

5. Vartanov VYa, Krugova LV, Shifman EM. 2012. Narusheniya gemostaza u VICh-infitsirovannyih beremennyih na fone himioprofilaktiki antiretrovirusnyimi preparatami i puti ih korrektsii. Anesteziologiya i reanimatologiya 6.

6. Vereina NK, Sinitsyin SP, Chulkov VS. 2012. Dinamika pokazateley gemostaza pri fiziologicheski protekayuschey beremennosti. Klinicheskaya laboratornaya diagnostika 2.

7. VICh-infektsiya: psihologicheskie i sotsialnyie osnovyi issledovaniya i preventsii: uchebno-metodicheskoe posobie pod obsch. red. A.V. Shaboltas. SPb, SPbGU, Fakultet psihologii. 2012.

8. Yarovaya GA i dr. 2017. Vnutrenniy put svertyivaniya krovi. FGBOU DPO «Rossiyskaya meditsinskaya akademiya nepreryivnogo professionalnogo obrazovaniya». M, FGBOU DPO RMANPO:68.

9. Voytsehovskiy VV i dr. 2014. Gemorragicheskiy sindrom v klinicheskoy praktike. Blagoveschensk, OOO «PK Odeon»:254.

10. Інформаційний бюлетень № 45 «Віл-інфекція в Україні» від 2016 р.

11. Lavrinenko VA, Babina AV. 2015. Fiziologiya krovi dlya studentov KRI: Uchebno-metodicheskoe posobie. Novosibirskiy gosudarstvennyiy universitet 116.

12. Medved VI. 2015. Venoznyiy tromboembolizm v akusherstve. Osnovnyie polozheniya mezhdunarodnyih i natsionalnyih rekomendatsiy. Meditsinskie aspektyi zdorovya zhenschinyi 10:5–9.

13. Momot AP i dr. 2014. Osobennosti sosudisto-trombotsitarnogo gemostaza na raznyih srokah fiziologicheskoy beremennosti. Meditsinskiy alfavit 1;2:27–31.

14. Novitskiy VV, Goldberg ED, Urazova OI. 2012. Patofiziologiya: uchebnik v 2-h tomah. M, Geotar-Media.

15. Fiyas AT, Ersh IR. 2013. Osnovyi klinicheskoy gematologii: ucheb. posobie. Minsk: Vyish. shk.:271.

16. Pavlovskaya YuM, Vorobeva NA. 2015. Fibrinogen i faktor XIII pri beremennosti. Zhurnal mediko-biologicheskih issledovaniі 1.

17. Vismont FI i dr. 2016. Patologicheskaya fiziologiya: rabochaya tetrad. Belorus. gos. med. un-t, kaf. patolog. fiziologii. Minsk: BGMU:194.

18. Leonova EV, Vismont FI. 2013. Patofiziologiya sistemyi krovi. 2-e izd., ispr. i dop. Minsk: Vyish. shk.:144.

19. Fiziologiya: uchebnik dlya studentov lecheb. i pediatr. fak-tov. Pod red. VM Smirnova, VA Pravdivtseva, DS Sveshnikova. 5-e izd., ispr. i dop. M, Meditsinskoe informatsionnoe agentstvo. 2017:512.

20. Shishonok AI, Scherbakova IG, Grebennikova IV. 2015. Sovremennyie aspektyi gemostaza. Mezhdunarodnyiy studencheskiy nauchnyiy vestnik. Elektronnyiy nauchnyiy zhurnal. Penza. 2:123–126.

21. Funderburg NT. 2014. Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients. Current opinion in HIV and AIDS. 9;1:80.

22. Karlsson O. 2014. Haemostasis during pregnancy, labour and postpartum haemorrhage.

23. Kiefer E et al. 2014. Association of markers of hemostasis with death in HIV-infected women. Journal of acquired immune deficiency syndromes (1999). 67;3:287.

24. Sule AA et al. 2013. Risk of venous thromboembolism in patients infected with HIV: a cohort study. The International journal of angiology: official publication of the International College of Angiology, Inc. 22;2:95.